Authors:
Sheridan, PL
Bodner, M
Lynn, A
Phuong, TK
DePolo, NJ
de la Vega, DJ
O'Dea, J
Nguyen, K
McCormack, JE
Driver, DA
Townsend, K
Ibanez, CE
Sajjadi, NC
Greengard, JS
Moore, MD
Respess, J
Chang, SMW
Dubensky, TW
Jolly, DJ
Sauter, SL
Citation: Pl. Sheridan et al., Generation of retroviral packaging and producer cell lines for large-scalevector production and clinical application: Improved safety and high titer, MOL THER, 2(3), 2000, pp. 262-275
Citation: Jb. Rosenberg et al., Genetic induction of a releasable pool of factor VIII in human endothelialcells, ART THROM V, 20(12), 2000, pp. 2689-2695
Authors:
Roehl, HH
Leibbrandt, MEI
Greengard, JS
Kamantigue, E
Glass, WG
Giedlin, M
Boekelheide, K
Johnson, DE
Jolly, DJ
Sajjadi, NC
Citation: Hh. Roehl et al., Analysis of testes and semen from rabbits treated by intravenous injectionwith a retroviral vector encoding the human factor VIII gene: No evidence of germ line transduction, HUM GENE TH, 11(18), 2000, pp. 2529-2540
Citation: Js. Greengard et Dj. Jolly, Animal testing of retroviral-mediated gene therapy for factor VIII deficiency, THROMB HAEM, 82(2), 1999, pp. 555-561
Authors:
DePolo, NJ
Harkleroad, CE
Bodner, M
Watt, AT
Anderson, CG
Greengard, JS
Murthy, KK
Dubensky, TW
Jolly, DJ
Citation: Nj. Depolo et al., The resistance of retroviral vectors produced from. Human cells to serum inactivation in vivo and in vitro is primate species dependent, J VIROLOGY, 73(8), 1999, pp. 6708-6714